The company is celebrating its 25th anniversary. Over these years PROTEK has grown from a small company into the largest Russian pharmaceutical holding, passed different stages of its formation including building of a distribution business of the CV PROTEK, development of Rigla retail network, and Sotex expansion. An important step in the development of the company was entering the public capital markets through IPO (initial public offering) in 2010.
25 years is just the beginning, as PROTEK continues to make progress, constantly being improved and aiming at long and successful company history. PROTEK group of companies is proud of the results achieved and is confident in its future.
On November 11, 2015 the Ministry of Industry and Trade of the Russian Federation issued a Russian GMP certificate to CLOSED JOINT STOCK COMPANY FarFirm Sotex (Report No. GMP-0038-000082/15).
Sotex has introduced new pharmaceuticals to the national market such as Flamadex, Neipilept, Lipothioxon, Ketoaminol, Ornilatex, Selamerex. A new (third one) ampoule medication production train has been launched. This will allow Sotex to double its volume of injection drugs production.
FarmFirm Sotex won silver in the 2014 Ad Eaters and won Best Commercial Video 2014 in the contest for its promotional video of Influnet, AnviMax also became the winner of the First International Green Cross Pharmaceutical Award in the Pharmaceutical of the Year - Cold and Flu Medicine nomination.
CV PROTEK has started the construction of a new warehouse up to 42,000 pallet positions in Pushkino.
Opening of the 1000th Rigla pharmacy in Moscow, MEGA Teply Stan Shopping Center at the following address: Moscow Oblast, Leninsky District, Kaluzhskoye shosse, 21th km (or 41-st km MKAD).
PROTEK implemented an electronic system to exchange documents with customers, pharmacies and pharmacy chains. From this moment on, clients of the largest national distributor will be able to receive and sign all bills and invoices in electronic format.
CV PROTEK opened a new branch with storage facility of more than 1000 m2 in Yakutsk
CV PROTEK was acknowledged as "the most influential pharmaceutical distributor in 2012" and was ranked first in the appropriate rating category of influence of certain subjects on the pharmaceutical market in Russia in 2012. The rating was published by Pharmaceutical Vestnik newspaper.
CV PROTEK won the “IT-LEADER" prize in the "Chemical and pharmaceutical industry" nomination for its outstanding contribution to the development of information technologies in Russia.
SOTEX ”PHARM FIRM” CJSC and Human Stem Cell Institute OJSC (HSCI) signed the agreement for a new drug Neovaskulgen supply developed by HSCI and destined for lower limb ischemia treatment.
CV PROTEK Company was rated first in “Logistics Operator of Russia 2013” in “National operator of the supply chain in the pharmaceutical industry" category as well as it was acknowledged leader in the “Top-10 Leaders of the logistics services market”.
Rigla Company, the largest pharmacy chain on the Russian market, announced the launch of the franchising program.
CV PROTEK launched a new project - "Customer’s Portal" - a unique resource that provides additional opportunities for pharmacies. Pharmacy managers and pharmacists are given the opportunity to interact quickly with the distributors and receive the relevant industry information on one website.
In Russia’s largest companies ranking “Expert-400” PROTEK OJSC won the 65th place in terms of volume implementation for 2012 and the 71st place in the capitalization rating.